Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia

Authors:

Abstract
Quiz Ref ID A work group commissioned by the National Institute on Aging and the Alzheimer’s Association (NIA-AA) recently published a research framework for Alzheimer disease.1 The framework used a scheme for biomarker classification of research participants that was labeled AT(N) for amyloid, tau, and neurodegeneration (or neuronal injury) biomarkers. A and T biomarkers are specific for the hallmark neuropathologic indicators of Alzheimer disease (amyloid plaques and tau neurofibrillary tangles),2 while biomarkers of (N) (eg, atrophy on magnetic resonance imaging [MRI]) are not disease specific; this distinction was connoted by placing N in parentheses. With the application of cut points,3 each of A, T, or (N) can be classified as abnormal (+) or normal (−), resulting in 8 different AT(N) biomarker profiles.

This publication has 42 references indexed in Scilit: